Literature DB >> 30568745

Hormonal Treatment for Symptomatic Bone Marrow Metastasis in Breast Cancer Patients.

Cahyanur Rahmat1, Rinaldi Ikhwan1.   

Abstract

Breast cancer is the most common cancer in females worldwide and also in Indonesia. Symptomatic bone marrow metastasis is an uncommon presentation of metastatic breast cancer patient. A retrospective study showed that, out of 12970 patients with breast cancer, only 0.17% had symptomatic bone marrow metastasis. Management of patients with bone marrow metastasis also creates dilemma for the clinician. Risk and benefit from treatment should be discussed and carefully considered. We describe here a case report of a 58-year-old female patient with pancytopenia, who had a history of breast cancer four years before. A PET CT Scan showed multiple vertebrae bone metastasis. Bone marrow biopsy revealed marrow infiltration of metastasis breast cancer in bone marrow. This patient received hormonal treatment, which resulted in promising results for four months. Unfortunately, the patient did not come for control regularly and died due to hepatic failure caused by liver metastasis.

Entities:  

Year:  2018        PMID: 30568745      PMCID: PMC6290185          DOI: 10.26574/maedica.2018.13.3.238

Source DB:  PubMed          Journal:  Maedica (Bucur)        ISSN: 1841-9038


  4 in total

1.  Symptomatic bone marrow involvement in breast cancer--clinical presentation, treatment, and prognosis: a single institution review of 22 cases.

Authors:  Hans-Georg Kopp; Katja Krauss; Tanja Fehm; Annette Staebler; Jennifer Zahm; Wichard Vogel; Lothar Kanz; Frank Mayer
Journal:  Anticancer Res       Date:  2011-11       Impact factor: 2.480

2.  Palliative hormone therapy, low-dose chemotherapy, and bisphosphonate in breast cancer patients with bone marrow involvement and pancytopenia: report of a pilot experience.

Authors: 
Journal:  Eur J Intern Med       Date:  2000-12-20       Impact factor: 4.487

3.  [A case of recurrent breast cancer with bone marrow metastasis treated with weekly paclitaxel therapy].

Authors:  Shinsuke Sasada; Goro Yokoyama; Hiroki Takahashi; Kenta Koike; Koji Ikejiri; Teruhiko Fujii
Journal:  Gan To Kagaku Ryoho       Date:  2008-09

4.  Stabilization of bone marrow infiltration by metastatic breast cancer with continuous doxorubicin.

Authors:  Gaurav Pahouja; Robert Wesolowski; Raquel Reinbolt; Gary Tozbikian; Michael Berger; Neha Mangini; Maryam B Lustberg
Journal:  Cancer Treat Commun       Date:  2015
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.